Compare $DXR vs $OM | Chartloom

Compare

$DXR vs $OM

Daxor Corp · Outset Medical Inc

DXR

Daxor Corp

Outset Medical Inc

Compare $DXR vs $OM

Comparing Daxor Corp and Outset Medical Inc

DXRDaxor Corp

OMOutset Medical Inc

DXRDaxor Corp

Market cap

$61M

P/E (TTM)

10.55x

Forward P/E (NTM)

—

Forward P/S (NTM)

4.27x

Rev growth (TTM)

-52.9%

YTD performance

-27.5%

52W performance

-11.3%

FCF yield

-13.5%

OMOutset Medical Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.56x

Rev growth (TTM)

-1.3%

YTD performance

9.5%

52W performance

-74.4%

FCF yield

-51.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DXR

Detailed metrics comparison

DXR

Daxor Corp

Outset Medical Inc

Market Cap

DXR$61M

OM$75M

Enterprise Value

DXR$61M

OM$138M

Price

DXR$10.41

OM$4.05

P/E Ratio

DXR10.55x

OMN/A

P/S Ratio

DXR1,942.31x

OM0.64x

EV/Sales

DXR1,942.31x

OM1.17x

EV/EBITDA

DXR6,283.06x

OM0.00x

P/B Ratio

DXR1.21x

OM0.77x

P/FCF Ratio

DXRN/A

OMN/A

EV/FCF

DXR-7.43x

OM-3.56x

PEG Ratio

DXRN/A

OMN/A

Forward P/E (NTM)

DXRN/A

OMN/A

Forward P/S (NTM)

DXR4.27x

OM0.56x

Revenue (TTM)

DXR$31K

OM$118M

Revenue Growth (YoY)

DXR-52.9%

OM-1.3%

Forward Rev Growth

DXR76.3%

OM10.5%

Gross Margin (TTM)

DXR-5782.1%

OM41.8%

Operating Margin (TTM)

DXR0.0%

OM0.0%

EBITDA Margin (TTM)

DXR-6055.0%

OM-53.2%

Net Margin (TTM)

DXR19899.7%

OM-63.1%

FCF Margin (TTM)

DXR-26130.7%

OM-33.0%

Net Income (TTM)

DXR$6M

OM$-74M

FCF (TTM)

DXR$-8M

OM$-39M

EPS (TTM)

DXR$0.99

OM-$3.99

ROE (TTM)

DXR12.8%

OM-6225.0%

ROA (TTM)

DXR12.7%

OM-2875.0%

ROIC (TTM)

DXR12.8%

OM-3438.0%

Cash

DXR$0

OM$35M

Debt

DXR$0

OM$98M

Net Cash/Debt

DXR$0

OM$-63M

Current Ratio (TTM)

DXR2.88x

OM5.19x

Quick Ratio (TTM)

DXR2.88x

OM4.02x

Debt/Equity (TTM)

DXR0.00x

OM1.02x

Debt/Assets (TTM)

DXR0.0%

OM0.0%

Interest Coverage (TTM)

DXRN/A

OMN/A

Net Debt/EBITDA (TTM)

DXR0.00x

OM0.00x

Beta

DXR0.38

OM2.01

52W Performance

DXR-11.3%

OM-74.4%

YTD Performance

DXR-27.5%

OM9.5%

% from 52W High

DXR-29.5%

OM-74.9%

% from 52W Low

DXR21.6%

OM42.6%

Asset Turnover (TTM)

DXR0.00x

OM0.46x

FCF Yield (TTM)

DXR-13.5%

OM-51.8%

Earnings Yield (TTM)

DXR10.2%

OM-98.9%

Dividend Yield (TTM)

DXRN/A

OMN/A

Rule of 40

DXR-26,183.5

OM-34.3

EV/GP/RG

DXRN/A

OM0.04

Ticker research

View DXR research View OM research

Metric	DXR Daxor Corp	OM Outset Medical Inc
Market & Valuation
Market Cap	$61M	$75M
Enterprise Value	$61M	$138M
Price	$10.41	$4.05
P/E Ratio	10.55x	N/A
P/S Ratio	1,942.31x	0.64x
EV/Sales	1,942.31x	1.17x
EV/EBITDA	6,283.06x	0.00x
P/B Ratio	1.21x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.43x	-3.56x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.27x	0.56x
Revenue & Growth
Revenue (TTM)	$31K	$118M
Revenue Growth (YoY)	-52.9%	-1.3%
Forward Rev Growth	76.3%	10.5%
Profitability
Gross Margin (TTM)	-5782.1%	41.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6055.0%	-53.2%
Net Margin (TTM)	19899.7%	-63.1%
FCF Margin (TTM)	-26130.7%	-33.0%
Net Income (TTM)	$6M	$-74M
FCF (TTM)	$-8M	$-39M
EPS (TTM)	$0.99	-$3.99
ROE (TTM)	12.8%	-6225.0%
ROA (TTM)	12.7%	-2875.0%
ROIC (TTM)	12.8%	-3438.0%
Financial Health
Cash	$0	$35M
Debt	$0	$98M
Net Cash/Debt	$0	$-63M
Current Ratio (TTM)	2.88x	5.19x
Quick Ratio (TTM)	2.88x	4.02x
Debt/Equity (TTM)	0.00x	1.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.38	2.01
52W Performance	-11.3%	-74.4%
YTD Performance	-27.5%	9.5%
% from 52W High	-29.5%	-74.9%
% from 52W Low	21.6%	42.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.46x
FCF Yield (TTM)	-13.5%	-51.8%
Earnings Yield (TTM)	10.2%	-98.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-26,183.5	-34.3
EV/GP/RG	N/A	0.04
Ticker research	View DXR research	View OM research

Valuation

P/E Ratio

DXR

10.55x

P/S Ratio

0.64x

DXR

1,942.31x

EV/FCF

DXR

-7.43x

-3.56x

Growth & revenue

Revenue Growth TTM

-1.3%

DXR

-52.9%

Forward Revenue Growth

DXR

76.3%

10.5%

Profitability & performance

Gross Margin

41.8%

DXR

-5782.1%

ROE

DXR

12.8%

-6225.0%

FCF Yield %

DXR

-13.5%

-51.8%

52-Week Performance

DXR

-11.3%

-74.4%

Detailed metrics comparison

DXR

Daxor Corp

Outset Medical Inc

Market Cap

DXR$61M

OM$75M

Enterprise Value

DXR$61M

OM$138M

Price

DXR$10.41

OM$4.05

P/E Ratio

DXR10.55x

OMN/A

P/S Ratio

DXR1,942.31x

OM0.64x

EV/Sales

DXR1,942.31x

OM1.17x

EV/EBITDA

DXR6,283.06x

OM0.00x

P/B Ratio

DXR1.21x

OM0.77x

P/FCF Ratio

DXRN/A

OMN/A

EV/FCF

DXR-7.43x

OM-3.56x

PEG Ratio

DXRN/A

OMN/A

Forward P/E (NTM)

DXRN/A

OMN/A

Forward P/S (NTM)

DXR4.27x

OM0.56x

Revenue (TTM)

DXR$31K

OM$118M

Revenue Growth (YoY)

DXR-52.9%

OM-1.3%

Forward Rev Growth

DXR76.3%

OM10.5%

Gross Margin (TTM)

DXR-5782.1%

OM41.8%

Operating Margin (TTM)

DXR0.0%

OM0.0%

EBITDA Margin (TTM)

DXR-6055.0%

OM-53.2%

Net Margin (TTM)

DXR19899.7%

OM-63.1%

FCF Margin (TTM)

DXR-26130.7%

OM-33.0%

Net Income (TTM)

DXR$6M

OM$-74M

FCF (TTM)

DXR$-8M

OM$-39M

EPS (TTM)

DXR$0.99

OM-$3.99

ROE (TTM)

DXR12.8%

OM-6225.0%

ROA (TTM)

DXR12.7%

OM-2875.0%

ROIC (TTM)

DXR12.8%

OM-3438.0%

Cash

DXR$0

OM$35M

Debt

DXR$0

OM$98M

Net Cash/Debt

DXR$0

OM$-63M

Current Ratio (TTM)

DXR2.88x

OM5.19x

Quick Ratio (TTM)

DXR2.88x

OM4.02x

Debt/Equity (TTM)

DXR0.00x

OM1.02x

Debt/Assets (TTM)

DXR0.0%

OM0.0%

Interest Coverage (TTM)

DXRN/A

OMN/A

Net Debt/EBITDA (TTM)

DXR0.00x

OM0.00x

Beta

DXR0.38

OM2.01

52W Performance

DXR-11.3%

OM-74.4%

YTD Performance

DXR-27.5%

OM9.5%

% from 52W High

DXR-29.5%

OM-74.9%

% from 52W Low

DXR21.6%

OM42.6%

Asset Turnover (TTM)

DXR0.00x

OM0.46x

FCF Yield (TTM)

DXR-13.5%

OM-51.8%

Earnings Yield (TTM)

DXR10.2%

OM-98.9%

Dividend Yield (TTM)

DXRN/A

OMN/A

Rule of 40

DXR-26,183.5

OM-34.3

EV/GP/RG

DXRN/A

OM0.04

Ticker research

View DXR research View OM research

Metric	DXR Daxor Corp	OM Outset Medical Inc
Market & Valuation
Market Cap	$61M	$75M
Enterprise Value	$61M	$138M
Price	$10.41	$4.05
P/E Ratio	10.55x	N/A
P/S Ratio	1,942.31x	0.64x
EV/Sales	1,942.31x	1.17x
EV/EBITDA	6,283.06x	0.00x
P/B Ratio	1.21x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.43x	-3.56x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.27x	0.56x
Revenue & Growth
Revenue (TTM)	$31K	$118M
Revenue Growth (YoY)	-52.9%	-1.3%
Forward Rev Growth	76.3%	10.5%
Profitability
Gross Margin (TTM)	-5782.1%	41.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6055.0%	-53.2%
Net Margin (TTM)	19899.7%	-63.1%
FCF Margin (TTM)	-26130.7%	-33.0%
Net Income (TTM)	$6M	$-74M
FCF (TTM)	$-8M	$-39M
EPS (TTM)	$0.99	-$3.99
ROE (TTM)	12.8%	-6225.0%
ROA (TTM)	12.7%	-2875.0%
ROIC (TTM)	12.8%	-3438.0%
Financial Health
Cash	$0	$35M
Debt	$0	$98M
Net Cash/Debt	$0	$-63M
Current Ratio (TTM)	2.88x	5.19x
Quick Ratio (TTM)	2.88x	4.02x
Debt/Equity (TTM)	0.00x	1.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.38	2.01
52W Performance	-11.3%	-74.4%
YTD Performance	-27.5%	9.5%
% from 52W High	-29.5%	-74.9%
% from 52W Low	21.6%	42.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.46x
FCF Yield (TTM)	-13.5%	-51.8%
Earnings Yield (TTM)	10.2%	-98.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-26,183.5	-34.3
EV/GP/RG	N/A	0.04
Ticker research	View DXR research	View OM research